forphenicinol has been researched along with Carcinoma, Ehrlich Tumor in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishizuka, M; Kanbayashi, N; Masuda, T; Matsuzaki, M; Ohkura, A; Sawazaki, Y; Takeuchi, T; Umezawa, H; Watanabe, Y | 1 |
1 other study(ies) available for forphenicinol and Carcinoma, Ehrlich Tumor
| Article | Year |
|---|---|
Antitumor effect of forphenicinol, a low molecular weight immunomodifier, on murine transplantable tumors and microbial infections.
Topics: Adjuvants, Immunologic; Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Cyclophosphamide; Female; Glycine; Leukemia L1210; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Pseudomonas Infections; Sarcoma 180 | 1982 |